The number of cancer survivors continues to increase due to the aging and growth of the
population and improvements in early detection and treatment. In order for the public health …

Context Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive
and advanced prostate cancer, but it has also been associated with adverse effects on bone …

The number of cancer survivors continues to increase in the United States because of the
growth and aging of the population as well as advances in early detection and treatment. To …

The number of cancer survivors continues to increase because of both advances in early
detection and treatment and the aging and growth of the population. For the public health …

Background In advanced prostate cancer (APC), successful drug development as well as
advances in imaging and molecular characterisation have resulted in multiple areas where …

Background Sipuleucel-T, an autologous active cellular immunotherapy, has shown
evidence of efficacy in reducing the risk of death among men with metastatic castration …

OBJECTIVE This study evaluated the effects of testosterone replacement therapy (TRT) on
insulin resistance, cardiovascular risk factors, and symptoms in hypogonadal men with type …

Importance Owing to improved survival among US patients with prostate cancer (PC),
patients tend to live long enough after a PC diagnosis for non–cancer-related comorbidities …

Context Whether androgen deprivation therapy (ADT) causes excess cardiovascular deaths
in men with prostate cancer is highly controversial and was the subject of a joint statement …

Background Previous studies indicate that androgen deprivation therapy for prostate cancer
is associated with diabetes and cardiovascular disease among older men. We evaluated the …